-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $750

Benzinga·10/16/2026 15:58:02
Diffusion vocale
JP Morgan analyst Chris Schott maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $775 to $750.